Back to top
more

Masimo (MASI)

(Delayed Data from NSDQ)

$115.05 USD

115.05
306,435

+1.03 (0.90%)

Updated Sep 4, 2024 04:00 PM ET

After-Market: $115.15 +0.10 (0.09%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value B Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (77 out of 251)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

IDEXX Laboratories (IDXX), Great Growth Pick: Here's Why

Banking on a number of favorable metrics, IDEXX Laboratories (IDXX) stands out as one of the most suitable growth stock.

    Is Amedisys (AMED) a Great Value Stock for Your Portfolio?

    Banking on a number of favorable metrics, Amedisys (AMED) stands out as one of the most suitable value stock.

      Here's Why Masimo (MASI) is a Suitable Value Pick for Now

      Masimo (MASI) seems to be a solid value pick with favorable P/E ratio and P/FCF ratio compared with its broader industry.

        McKesson Banks on Distribution Business Amid Pricing Woes

        McKesson (MCK) entered fiscal 2018 with an assumption of branded inflation in the mid-single digits. Pricing pressure in the independent retail pharmacy channel is a headwind.

          BioTelemetry Hits a 52-Week High: What's Driving the Stock?

          BioTelemetry (BEAT) is putting efforts in product innovation through research and development. The company recently announced the acquisition of LifeWatch AG in a deal valued at about $280 million.

            Masimo (MASI) Introduces SafetyNet System in Dubai Hospitals

            Masimo's (MASI) proprietary Patient SafetyNet system's introduction in the Dubai market is in line with its strategy of becoming the dominant player in the pulse oximetry market.

              Zacks.com featured highlights: CBRE Group, Canadian Pacific Railway, East West Bancorp, Hasbro and Masimo

              Zacks.com featured highlights: CBRE Group, Canadian Pacific Railway, East West Bancorp, Hasbro and Masimo

                Top 5 GARP Stocks to Scoop Up Right Now

                The GARP approach prefers stocks that are priced below the market or any reasonable target determined by fundamental analysis.

                  Masimo (MASI) Beats on Q2 Earnings and Revenues, Guides Up

                  Masimo's (MASI) stable performance across its businesses was the key highlight of second quarter.

                    MedTech Stock Earnings Slated for Aug 2: CAH, HOLX & More

                    Despite solid strategic initiatives, the ongoing political conundrum at the Capitol Hill is likely to affect earnings results of these four major Medical Technology bigwigs.

                      Masimo (MASI) Rainbow Super DCI-mini Sensor Now CE Marked

                      Irvine, CA-based Masimo Corporation (MASI) recently announced the receipt of CE mark for the noninvasive and reusable rainbow Super DCI-mini sensor.

                        Masimo (MASI) Presents Utility Study of Oxygen Reserve Index

                        Masimo Corporation (MASI) recently announced data from its study evaluating the potential clinical utility of Masimo Oxygen Reserve Index.

                          Zacks.com featured highlights: 58.com, RPC, U.S. Silica Holdings, Masimo and Manitowoc

                          Zacks.com featured highlights: 58.com, RPC, U.S. Silica Holdings, Masimo and Manitowoc

                            Tirthankar Chakraborty headshot

                            5 Stocks to Watch for Accelerating Earnings Growth

                            Earnings acceleration should be viewed as a key metric for share price outperformance

                              Masimo (MASI) O3 Regional Oximetry Device Gets FDA Nod

                              Masimo Corporation (MASI) recently announced the receipt of FDA 510(k) clearance for O3 regional oximetry device.

                                Masimo (MASI) Beats on Q1 Earnings and Revenues, Guides Up

                                Masimo Corp. (MASI) reported earnings of 57 cents per share in the first quarter of 2017, outperforming the Zacks Consensus Estimate of 54 cents and improving from the year-ago quarterly earnings of 53 cents.

                                  Zacks.com featured highlights: Ituran Location and Control, Molina Healthcare, WellCare Health Plans and Masimo

                                  Zacks.com featured highlights: Ituran Location and Control, Molina Healthcare, WellCare Health Plans and Masimo

                                    4 Top-Ranked Liquid Stocks for a Winning Portfolio

                                    Liquidity of a stock primarily indicates a company's capability to meet debt obligations by converting assets into liquid cash and equivalents.

                                      After ISRG Q1 Earnings, 3 Medical Instrument Stocks Looking Up

                                      While the Medical Instrument industry has been oscillating between hope and despair, let us take a look at three stocks which are expected to put up an impressive show this earnings season like Intuitive Surgical.

                                        Masimo (MASI) Launches Root Platform with Kite Trademark

                                        Irvine, CA-based Masimo Corporation (MASI) announced full market release of the Root monitoring platform with a Kite trademark (a supplementary display system).

                                          Obamacare Holds Ground: 3 Medical Device Stocks to Gain

                                          Republican leaders have failed to play their "Trump card" this time, courtesy of the pullback of the Republican healthcare bill, the American Health Care Act (ACHA), which was designed to repeal the Affordable Care Act (ACA) or Obamacare.

                                            Masimo (MASI) Up 20.6% Since Earnings Report: Can It Continue?

                                            Masimo (MASI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                              3 Medical Device Stocks to Brave Policy Uncertainty

                                              We believe stocks with strong fundamentals that also have a significant share of their business overseas may well brace themselves in the on-going conundrum. They will make lucrative additions to your portfolio.

                                                Can The Uptrend Continue for Masimo (MASI)?

                                                Investors certainly have to be happy with Masimo Corporation (MASI) and its short term performance

                                                  Masimo Announces Availability of RD SedLine Brain Sensors

                                                  Masimo Corporation (MASI) recently announced the availability of the RD SedLine EEG sensor, which can be used with the company???s flagship SedLine Brain Function Monitoring technology.